Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer

NCT03180294 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

230

Enrollment

OTHER

Sponsor class

Conditions

Breast Carcinoma
Cervical Carcinoma
Ovarian Carcinoma
Postmenopausal
Uterine Corpus Cancer
Vaginal Carcinoma
Vulvar Carcinoma

Interventions

DRUG: Bupropion 150 mg XL
DRUG: Placebo

Sponsor

NRG Oncology

Collaborators

[object Object]